Synovus price target lowered to $62 from $65 at Barclays

Barclays analyst Jared Shaw lowered the firm’s price target on Synovus (SNV) to $62 from $65 and keeps an Overweight rating on the shares as part of a Q3 earnings preview for the mid-cap banks. Loan growth and deposit cost control should help drive earnings beats and positive guidance revisions, the analyst tells investors in a research note. Barclays believes another quarter of “clean credit” and good balance sheet trends “could pull investors off the sidelines.”